Skip to menu Skip to content Skip to footer

An Innovative, Non-Hormonal, Pharmacological Strategy that Down-Regulates the Oestrogen, Androgen, Progesterone, and Prolactin Receptors and Inhibits the Triad-of-Death in Breast Cancer (Griffith led) (2023-2026)

Experts

Professor Paul Bernhardt

Professor
School of Chemistry and Molecular Biosciences
Faculty of Science
Paul Bernhardt
Paul Bernhardt